progenesis same spots ver5.0 (Nonlinear Dynamics)
90
Structured Review
Nonlinear Dynamics
progenesis same spots ver5.0
Progenesis Same Spots Ver5.0, supplied by Nonlinear Dynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/progenesis+same+spots+ver5%2E0/progenesis+same+spots+ver5+0/pm28534505-135-22-26
Average 90 stars, based on 1 article reviews
Progenesis Same Spots Ver5.0, supplied by Nonlinear Dynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/progenesis+same+spots+ver5%2E0/progenesis+same+spots+ver5+0/pm28534505-135-22-26
Average 90 stars, based on 1 article reviews
progenesis same spots ver5.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Stripping Membranes:Article Title: Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp. Article Snippet: Mutation of the TP53 gene represents a prevalent genetic alteration in human cancers, and a subset of p53 mutants may form amyloid-like aggregates that contribute to the gain of oncogenic functions (GOFs) and chemoresistance.. Here we identify the pathways that may mediate the aggregation-associated GOF by using combined proteomic analysis and genome-wide recruitment profiling.. Mass spectrometry revealed activation of unfolded protein response (UPR) pathway and upregulation of endoplasmic reticulum protein 29 (ERp29) in TP53-expressing cells that were exposed to cisplatin stress. Staining:Article Title: Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp. Article Snippet: Mutation of the TP53 gene represents a prevalent genetic alteration in human cancers, and a subset of p53 mutants may form amyloid-like aggregates that contribute to the gain of oncogenic functions (GOFs) and chemoresistance.. Here we identify the pathways that may mediate the aggregation-associated GOF by using combined proteomic analysis and genome-wide recruitment profiling.. Mass spectrometry revealed activation of unfolded protein response (UPR) pathway and upregulation of endoplasmic reticulum protein 29 (ERp29) in TP53-expressing cells that were exposed to cisplatin stress. Software:Article Title: Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp. Article Snippet: Mutation of the TP53 gene represents a prevalent genetic alteration in human cancers, and a subset of p53 mutants may form amyloid-like aggregates that contribute to the gain of oncogenic functions (GOFs) and chemoresistance.. Here we identify the pathways that may mediate the aggregation-associated GOF by using combined proteomic analysis and genome-wide recruitment profiling.. Mass spectrometry revealed activation of unfolded protein response (UPR) pathway and upregulation of endoplasmic reticulum protein 29 (ERp29) in TP53-expressing cells that were exposed to cisplatin stress. |